CUV 0.49% $14.23 clinuvel pharmaceuticals limited

huntley's report:, page-4

  1. 1,363 Posts.
    Weekly and monthly charts still in clear uptrend, daily looks a little different, but its too early to call it a down trend. Stock was over bought in April (on NO news I might add) so a retracement was always on the cards, take all of the april buying out and it all looks rosy. Word is it was Bank of N.Y buying in april anyway (20 mil shares for level one adr) ,good support at $0.80 will hold imho. You won't get them below this. There's too much positive news on the horizon.

    As I've said before - Patience Grasshoppers!

    ps. the BBY report gave ept a potential value of $3.80 to $5.00!!!, so relax.

    cheers, stainless
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.